ACTIVE

Microbial Resource Management Technologies

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-99,7 k €
-101.7% YoY
Gross margin
65,6 k €
-98.9% YoY
Equity
12,3 M €
-0.8% YoY
Workforce
0,0 ETP

What does Microbial Resource Management Technologies do?

Microbial Resource Management Technologies is a Public limited company incorporated in 2016. Its registered office is in Gent.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0667.765.816
Incorporation
15/12/2016
Legal form
Public limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
6 982 172,00 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Signals
Solid equityLow riskPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232022202120182017
Income statement
Gross margin65,6 k €5,9 M €65,1 k €166,7 k €131,0 k €52,2 k €25,3 k €
EBITDA64,4 k €5,9 M €-129,9 k €31,8 k €129,2 k €51,8 k €24,5 k €
Operating result-2,2 k €5,8 M €-242,3 k €-103,4 k €5,3 k €3,7 k €670,8 €
Net result-99,7 k €5,8 M €-262,7 k €-106,6 k €1,1 k €236,3 €154,0 €
Balance sheet
Equity12,3 M €12,4 M €21,4 M €21,6 M €21,8 M €18,0 M €18,0 M €
Total assets14,6 M €29,5 M €24,0 M €22,3 M €22,0 M €18,2 M €18,1 M €
Cash3,0 k €2,6 k €119,0 k €97,2 k €926,9 k €1,1 M €1,6 M €
Debts2,0 M €16,9 M €2,6 M €660,2 k €288,6 k €214,8 k €93,6 k €
Other
Workforce0,0 ETP0,0 ETP0,0 ETP––––
Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 12 ended

Active mandates

OMX Europe Venture Fund FPCI

Director · since 10 mars 2026 · until 10 juin 2031 · 0774.597.656

Represented by Kristin Thompson

Active
Mérieux Equity Partners

Director · since 09 mars 2022 · until 06 octobre 2027 · 0742.922.505

Represented by Valérie CALENDA

Active
Massimo Marzorati

Director · since 12 décembre 2016 · until 08 juin 2028

Active
Sam Possemiers

Director · since 12 décembre 2016 · until 08 juin 2028

Active

Ended mandates

MERIEUX EQUITY PARTNERS SAS

Director · since 09 mars 2022 · until 10 juin 2027 · 0742.922.505

Represented by Valérie CALENDA

Ended
François Valencony

Director · since 27 septembre 2021 · until 09 mars 2022

Ended
KORYS MANAGEMENT

Director · since 06 novembre 2017 · until 10 juin 2024 · 0885.971.571

Represented by David DEVIGNE

Ended
KORYS MANAGEMENT

Director · since 06 novembre 2017 · until 10 juin 2024 · 0885.971.571

Represented by Waer Christoph

Ended
At this address

Other companies at this address

CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Cryptobiotix● Active
0762.565.104
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
INNOVATIVE PHARMACEUTICS● Active
0883.574.582
Inspect● Active
0645.950.417
INVIBES ADVERTISING● Active
0836.533.938
KYTOS● Active
0768.755.286
Lares Solutions● Active
1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active
0755.350.975
Microbial Resource Management Health● Active
0742.910.132
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date11/09/202608/10/202511/07/202427/06/202328/06/202228/06/2021
General meeting30/06/202630/06/202513/06/202410/06/202309/06/202210/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

9 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202611/09/2026DutchPDF
Abridged model31/12/202430/06/202508/10/2025DutchPDF
Abridged model31/12/202313/06/202411/07/2024DutchPDF
Abridged model31/12/202210/06/202327/06/2023DutchPDF
Abridged model31/12/202109/06/202228/06/2022DutchPDF
Abridged model31/12/202010/06/202128/06/2021DutchPDF
Abridged model31/12/201901/09/202025/09/2020DutchPDF
Abridged model31/12/201811/06/201925/06/2019DutchPDF
Abridged model31/12/201725/06/201824/07/2018DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 12 ended

Active mandates

OMX Europe Venture Fund FPCI

Director · since 10 mars 2026 · until 10 juin 2031 · 0774.597.656

Represented by Kristin Thompson

Active
Mérieux Equity Partners

Director · since 09 mars 2022 · until 06 octobre 2027 · 0742.922.505

Represented by Valérie CALENDA

Active
Massimo Marzorati

Director · since 12 décembre 2016 · until 08 juin 2028

Active
Sam Possemiers

Director · since 12 décembre 2016 · until 08 juin 2028

Active

Ended mandates

MERIEUX EQUITY PARTNERS SAS

Director · since 09 mars 2022 · until 10 juin 2027 · 0742.922.505

Represented by Valérie CALENDA

Ended
François Valencony

Director · since 27 septembre 2021 · until 09 mars 2022

Ended
KORYS MANAGEMENT

Director · since 06 novembre 2017 · until 10 juin 2024 · 0885.971.571

Represented by David DEVIGNE

Ended
KORYS MANAGEMENT

Director · since 06 novembre 2017 · until 10 juin 2024 · 0885.971.571

Represented by Waer Christoph

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates28/10/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares31/12/2024
    KAPITAAL - AANDELEN
    PDF
  • Mandates07/04/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/10/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office11/03/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
    PDF
  • Mandates14/05/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/11/2017
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates30/01/2017
    ONTSLAGEN - BENOEMINGEN
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-99,7 k €↓
  2. 2024
    Annual accounts 20245,8 M €↑
  3. 2023
    Annual accounts 2023-262,7 k €↓
  4. 2022
    Annual accounts 2022-106,6 k €↓
  5. 2021
    Annual accounts 20211,1 k €↑
  6. 2018
    Annual accounts 2018236,3 €↑
  7. 2017
    Annual accounts 2017154,0 €
  8. 15/12/2016
    IncorporationPublic limited company